Blisovi Fe 1/20 Kit
Product Images NDC 68180-865
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Blisovi Fe 1/20 (NDC 68180-865). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
80ca76da 51ef 499f 988a 4ded69035439 02
80ca76da 51ef 499f 988a 4ded69035439 03
This is a table showing the mortality rates per 100,000 woman years by age, smoking status, and oral contraceptive use for circulatory diseases. The table is divided into two sections: ever-users (non-smokers) and controls (non-smokers), and ever-users (smokers) and controls (smokers). The age groups are 15-24, 25-34, and 35-44. The source of the table is P.M. Layde and V. Beral, Reference 18.*
80ca76da 51ef 499f 988a 4ded69035439 04
This text appears to be a collection of study names and results related to the use of combined oral contraceptives (COC). The studies include NICHD Women's Care Study, French E3N cohort study, shanghai Women's Health Study, The Nurses' Health Study II, and Oxford Family Planning Study among others. The results include effect estimations such as odds ratios (OR), relative risks (RR), and hazard ratios (HR) for the use of COC compared to never use in different population groups. However, there is no sufficient information on what health outcomes or conditions these studies were investigating, so it is difficult to provide any further interpretation.*
80ca76da 51ef 499f 988a 4ded69035439 05
80ca76da 51ef 499f 988a 4ded69035439 06
This is a calendar indicating the days of the week starting from Sunday. It is intended for tracking a menstrual cycle, and requires the user to place a label strip with the day of the week corresponding to the first day of their period. The text also mentions a self breast exam to be performed monthly, but no further information is provided.*
80ca76da 51ef 499f 988a 4ded69035439 07
This appears to be a product label for a medication called Blisovi, containing norethindrone acetate and etfinyl esradiol tablets with ferrous fumarate tablets. It includes instructions for storage and the manufacturer's information. The other text seems to be scans of various non-English characters and an unrelated schedule for a monthly self-breast exam.*
80ca76da 51ef 499f 988a 4ded69035439 08
Lupin Women's CareĀ® Blisovi~Fe 1/20 is an oral contraceptive intended to prevent pregnancy that contains norethindrone acetate and ethinyl estradiol tablets USP and ferrous fumarate tablets. The package is not child-resistant and each yellow tablet contains 1mg of norethindrone acetate and 0.02mg of ethinyl estradiol. The ferrous fumarate tablets are not USP for dissolution. The product does not protect against HIV infection or other sexually transmitted diseases. This information is intended for the patient to be provided by a physician. The package was manufactured on June 28th, 2010 in India. The website www.birthcontrolhealth.com may have additional information.*
80ca76da 51ef 499f 988a 4ded69035439 09
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.